You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (GenomeWeb) – IntegraGen today announced that its test kit for predicting patient response to anti-EGFR therapy has been CE-IVD marked, and the company will launch it in the European Union.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.